Since its inception over 15 years ago, DermaSilk has always been supported by good quality clinical trials to justify the claims that we make about its performance.
As a Class I Medical Device it is possible to create small scale studies which clearly demonstrate efficacy. In some cases, clinicians have adopted studies which can show the benefit of using DermaSilk versus not using it – on the same patient as the effect is purely local and only affects the quality of the skin which is covered by it.
Other studies are of the more conventional “Randomised, placebo controlled“ type, involving relatively large numbers of patients. All have been peer reviewed and published in highly respected Medical Journals, including the Journal of the British Association of Dermatologists.
One thing is common to all the studies – compared with either cotton control products or Standard treatment regimes, the addition of DermaSilk Therapeutic clothing had the ability to improve the parameters measured in symptom levels irrespective of the disease area being studied.
These papers and clinical abstracts form the majority of the clinical evidence supporting the use of silk clothing as a whole and justifying the place of DermaSilk in a number of European disease management guidelines.
A Randomized Double-Blind Study to lnvestigate the Clinical Efficacy of Adding a Non-Migrating Antimicrobial to a Special Silk Fabric in the Treatment of Atopic Dermatitis
Result: No difference between tubes for first 14 days but results favour antimicrobial tubes thereafter
Antimicrobial Silk Clothing in the Treatment of Atopic Dermatitis Proves Comparable to Topical Corticosteroid Treatment
Result: After 7 days of active treatment and a further 14 days of non-active treatment there were no differences between the use of Mometasone with cotton and DermaSilk
Evaluation of the Antibacterial Activity of a Special Silk Textile in the Treatment of Atopic Dermatitis
Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis
Result: Significant reduction in SCORAD in DermaSilk group compared to zero improvement in cotton group.
Promotive Effects of a Silk Film on Epidermal Recovery from Full-Thickness Skin Wounds
Action of a silk fabric treated with AEGIS(TM) in children with atopic dermatitis: A 3-month trial
Result: Significant reductions in SCORAD and subjective scores in favour of DermaSilk group. Improvements continued for all 12 weeks wheras cotton control areas started to deteriorate.
DermaSilk in long-term control of infantile atopic dermatitis: a double blind randomized controlled trial
Use of Dermasilk® knitted silk in children with dermatitis and mothers with nipple’s rhagades.
Dermatology Online Journal Volume 9 Number 2